billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 15,312
- 荣誉分数
- 4,772
- 声望点数
- 373
US Venture Capital Opens Path to Funding for China Biotech Firms
Five US startups funded in 2024 to develop drugs from China
Trend shows potential of China-originated assets, says analyst
说好的脱钩,资本家卖国。
不是美国不准投资中国生物科技吗?
A bill approved by the House of Representatives this week would make it difficult for U.S. drug companies to contract with five major Chinese biotechnology companies. Academic researchers say they, too, would be hampered. The new rules could threaten projects that rely on sequencing in China or involve Chinese scientists who use services or machines from the companies. It would also cut off one source of genome sequencers used in U.S. labs.